Literature DB >> 33338288

Testicular FDG-PET/CT uptake threshold in aggressive lymphomas.

Alexandra Higgins1, Hidong Kim1, Laura Harper2, Thomas M Habermann1, Grzegorz S Nowakowski1, Carrie A Thompson1, Patrick Johnston1, Thomas E Witzig1, Cristine Allmer3, Matthew J Maurer3, James R Cerhan4, Jason R Young2, Gita Thanarajasingam1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33338288      PMCID: PMC7902412          DOI: 10.1002/ajh.26073

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Primary testicular lymphoma.

Authors:  Chan Y Cheah; Andrew Wirth; John F Seymour
Journal:  Blood       Date:  2013-11-26       Impact factor: 22.113

2.  Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

Authors:  James R Cerhan; Brian K Link; Thomas M Habermann; Matthew J Maurer; Andrew L Feldman; Sergei I Syrbu; Carrie A Thompson; Umar Farooq; Anne J Novak; Susan L Slager; Cristine Allmer; Julianne J Lunde; William R Macon; David J Inwards; Patrick B Johnston; Ivana N M Micallef; Grzegorz S Nowakowski; Stephen M Ansell; Neil E Kay; George J Weiner; Thomas E Witzig
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

3.  Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.

Authors:  P Sidhu; P Lin; H Son; D Rosenfeld; M Lin
Journal:  Br J Radiol       Date:  2014-10-21       Impact factor: 3.039

4.  Normal uptake of 18F-FDG in the testis: an assessment by PET/CT.

Authors:  Kazuhiro Kitajima; Yuji Nakamoto; Michio Senda; Yumiko Onishi; Hiromi Okizuka; Kazuro Sugimura
Journal:  Ann Nucl Med       Date:  2007-09-25       Impact factor: 2.668

Review 5.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.